Mitsubishi Tanabe Pharma Canada Announces Treatment for Amyotrophic Lateral Sclerosis (ALS) now Eligible for Coverage through Veterans Affairs Canada and Indigenous Services Canada

TORONTO, Sept. 21, 2020 /CNW/ - Mitsubishi Tanabe Pharma Canada, Inc. (MTP-CA), a subsidiary of Mitsubishi Tanabe Pharma America, Inc. (MTPA), announced today that RADICAVA® (edaravone), an infusion treatment for amyotrophic lateral sclerosis......
. .
Veröffentlicht von: - Nachrichten Ticker - Monday, 21 September

Share |